As the old saying goes, “In life, a man must build a house, plant a tree and have a child.” The first two tasks are relatively easy to accomplish. Having a child, however, is a dream that more and more men are finding difficult and even impossible to fulfill in today’s world.

For a variety of reasons, fewer and fewer children are being born worldwide. Currently 10-15% of all couples worldwide are involuntarily childless. The causes of infertility are spread equally among women (the “female factor”) and men (the “male factor”), i.e. 50:50, a combination of both.


In 40-90% of cases, the cause of male infertility is deficient sperm production. Studies have shown a significant 58% decrease in sperm count over the last 50 years. 1,2

An analysis of over 100 published studies shows a significant trend of decreasing sperm density over the last 60 years, especially in the USA and Europe/Australia (-1-3% per year). 3,4

While there are numerous medical treatment options for women, in-vitro fertilization (IVF) as one example, the options available for men to improve their decisive factor–semen quality—are very limited.

1 Imhof M., Matthai C., Huber J.C. Einsatz von PROFORTIL® zur Therapie des „male factors“ und Verbesserung des Spermiogramms; Gyn-Aktiv 2007;2:68.
2 Sinclair S. Male infertility: nutritional and environmental considerations; Altern Med Rev 2000; 5(1):28-38.
3 Sween S.H., Elkin E.P., Fenster L. The question of declining sperm density revisited: An analysis of 101 studies published 1934-1996; Environmental Health Perspectives 2000; 108 (10).
4 Carlsen E., Giwercman A., Keiding N., Skakkebaek N. Evidence for decreasing quality of semen during past 50 years; Br Med J 1992; 305:609-61.

PROFORTIL® is the only tested and patented product that contributes to the optimization of sperm quality, offering an effective approach to male inferility. Extensive clinical studies have confirmed the effectiveness of the specific formula used in PROFORTIL®.